Lyons, France

Valérie Legrand



Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 169(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Valérie Legrand

Introduction

Valérie Legrand is a notable inventor based in Lyons, France. He has made significant contributions to the field of pharmaceuticals through his innovative inventions. His work focuses on developing systems that enhance the delivery and efficacy of active pharmaceutical ingredients.

Latest Patents

Valérie Legrand holds a patent for a microparticulate oral galenical form designed for the delayed and controlled release of pharmaceutical active principles. This invention addresses the challenge of ensuring that active principles, which have a limited absorption window in the gastrointestinal tract, are released effectively. The system utilizes a dual mechanism of 'time-dependent' and 'pH-dependent' release, ensuring therapeutic efficacy. The microparticulate system comprises microcapsules that are engineered to release the active principles in a controlled manner, enhancing their effectiveness.

Career Highlights

Legrand is associated with Flamel Technologies, a company known for its advancements in drug delivery systems. His work at Flamel Technologies has positioned him as a key player in the pharmaceutical innovation landscape. His patent reflects his commitment to improving patient outcomes through innovative drug delivery methods.

Collaborations

Valérie Legrand has collaborated with notable colleagues, including Catherine Castan and Rémi Meyrueix. These collaborations have contributed to the development of cutting-edge pharmaceutical technologies.

Conclusion

Valérie Legrand's contributions to the field of pharmaceuticals through his innovative patent demonstrate his dedication to enhancing drug delivery systems. His work continues to influence the industry and improve therapeutic outcomes for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…